Aptima® HPV Assays
Don’t Just Sense a Presence. Sense a Threat
Nearly all sexually active women and men will have an HPV infection at some point in their lives. Very few will go on to develop cancer.1 The Aptima HPV assay targets high-risk HPV mRNA.3 Studies have shown mRNA identifies the presence and activity of a high-risk HPV infection.2,3
The Aptima HPV assay targets the oncogenes E6/E7 mRNA, indicative of the HPV infections most likely to lead to disease.2,3
The Aptima® HPV 16 18/45 Genotype Assay deliver results for type 16, with separate combined result for HPV types 18 and 45, indicating high-risk carcinogenic potential for HPV positive patients.4,5 Identification of these types as part of reflex testing may identify up to 94% of all cervical adenocarcinomas.1
Maximising the Benefits of Screening Programs
Working With You to Advance Cervical Health
Advancing the Early Detection of Cervical Cancer
Aptima HPV Assay Design22
Aptima HPV Assay Overview
Evidence. Insight. Collaboration.
Our education portal improves patient care through excellence in education, communication of clinical and scientific evidence, and partnerships with the healthcare community.
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium.
Notified Body number wherever applicable